Clinical trial
Naltrexone for Relapse Prevention
NCT00000442 · UConn Health, Other · Completed
Key facts
| NCT number | NCT00000442 |
|---|---|
| Title | Naltrexone for Relapse Prevention |
| Official title | Etiology and Treatment of Alcohol Dependence |
| Lead sponsor | UConn Health, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | naltrexone (Revia) |
| Enrollment | 57 |
| Completion | Dec 1, 2002 |
| First posted | Nov 3, 1999 |
| Last update posted | Jun 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: